Evidence map›Paper›PMID 28210010›Full record

ArticleMedical archives (Sarajevo, Bosnia and Herzegovina)2016

Evaluation and Treatment of Anemia in Premature Infants.

Edo Hasanbegovic, Nermana Cengic, Snijezana Hasanbegovic, Jasmina Heljic, Ismail Lutolli, Edin Begic

Registry-linked trialAbstract read
In one paragraph

Article in Medical archives (Sarajevo, Bosnia and Herzegovina), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07358845 (Hematological Profiles of Preterm Infants), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07358845 completednot on this map

Hematological Profiles of Preterm Infants: Can it be Effected by Antenatal Steroids?

Typeobservational_patient_registrySponsorPrincess Anna Mazowiecka Hospital, Warsaw, PolandRan2011 to 2013Enrolled1,048ConditionsHaematologyArmsAntenatal Corticosteroid Exposure, Antenatal corticosteroids
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Edo HasanbegovicPediatric Clinic, University Clinical Center Sarajevo, Sarajevo, Bosnia and Herzegovina.
Nermana CengicPediatric Clinic, University Clinical Center Sarajevo, Sarajevo, Bosnia and Herzegovina.
Snijezana HasanbegovicPediatric Clinic, University Clinical Center Sarajevo, Sarajevo, Bosnia and Herzegovina.
Jasmina HeljicPediatric Clinic, University Clinical Center Sarajevo, Sarajevo, Bosnia and Herzegovina.
Ismail LutolliPediatric Clinic, University Clinical Center Sarajevo, Sarajevo, Bosnia and Herzegovina.
Edin BegicFaculty of Medicine, Sarajevo School of Science and Technology, Sarajevo, Bosnia and Herzegovina.
University of Sarajevo · BASarajevo School of Science and Technology · BA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAnemia in preterm infants is the pathophysiological process with greater and more rapid decline in hemoglobin compared to the physiological anemia in infants. There is a need for transfusions and administration of human recombinant erythropoietin.

aimTo determine the frequency of anemia in premature infants at the Pediatric Clinic, University Clinical Center Sarajevo, as well as parameter values in the blood count of premature infants and to explore a relationship between blood transfusions with the advent of intraventricular hemorrhage (determine treatment outcome in preterm infants). PATIENTS AND

methodsResearch is retrospective study and it included the period of six months in year 2014. Research included 100 patients, gestational age < 37 weeks (premature infants). Data were collected by examining the medical records of patients at the Pediatric Clinic, UCCS.

resultsThe first group of patients were premature infants of gestational age ≤ 32 weeks (62/100) and the second group were premature infants of gestational age 33-37 weeks (38/100). Among the patients, 5% were boys and 46% girls. There was significant difference in birth weight and APGAR score among the groups. In the first group, there were 27.42% of deaths, while in the second group, there were only 10.53% of deaths. There was a significant difference in the length of treatment. There was a statistically significant difference in the need for transfusion among the groups. 18 patients in the first group required a transfusion, while in the second group only 3 patients.

conclusionsPreterm infants of gestational age ≤ 32 weeks are likely candidates for blood transfusion during treatment. Preterm infants of gestational age ≤ 32 weeks have the risk of intracranial bleeding associated with the application of blood transfusion in the first week of life.

Indexed as

Blood TransfusionErythropoietinGestational AgeInfant, PrematureAnemia, NeonatalCerebral HemorrhageFemaleHemoglobinsHospitals, UniversityHumansInfant, Low Birth WeightInfant, NewbornMaleRetrospective StudiesSeverity of Illness IndexTreatment OutcomeErythropoietinHemoglobinsAnemiablood transfusionpreterm infants

Identifiers

PMID28210010
PMCPMC5292221
OpenAlexW2562800738

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.